Income tax expense · 2015–2025
Ascendis Pharma income tax expense
$17.4M+231.6% · FY2025
Ascendis Pharma (ASND) reported $17.4M in income tax expense for fiscal 2025, +231.6% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $17.4M | +231.6% | Open → |
| FY20242024-12-31 | $5.2M | −33.6% | Open → |
| FY20232023-12-31 | $7.9M | +39.5% | Open → |
| FY20222022-12-31 | $5.7M | +$6.1M | Open → |
| FY20212021-12-31 | −$434,066 | −$183,925 | Open → |
| FY20202020-12-31 | −$250,141 | +$11,816 | Open → |
| FY20192019-12-31 | −$261,957 | +$203,339 | Open → |
| FY20182018-12-31 | −$465,296 | +$73,562 | Open → |
| FY20172017-12-31 | −$538,858 | −$287,591 | Open → |
| FY20162016-12-31 | −$251,267 | +$472,135 | Open → |
| FY20152015-12-31 | −$723,402 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ascendis Pharma income tax expense |url=https://companiesranked.com/en/company/ascendis-pharma/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ascendis Pharma income tax expense. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/income-tax-expenseBibTeX
@misc{companiesranked-en-company-ascendis-pharma-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Ascendis Pharma income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026
{{cite web |title=Ascendis Pharma income tax expense — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.